JPS57206683A - Pyrimidone salt, manufacture and medicinal composition containing same - Google Patents

Pyrimidone salt, manufacture and medicinal composition containing same

Info

Publication number
JPS57206683A
JPS57206683A JP57089611A JP8961182A JPS57206683A JP S57206683 A JPS57206683 A JP S57206683A JP 57089611 A JP57089611 A JP 57089611A JP 8961182 A JP8961182 A JP 8961182A JP S57206683 A JPS57206683 A JP S57206683A
Authority
JP
Japan
Prior art keywords
pyrimidone
salt
manufacture
composition containing
medicinal composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57089611A
Other languages
English (en)
Japanese (ja)
Inventor
Reimondo Howaito Jiyooji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline & French Laboratories Ltd
Original Assignee
Smith Kline & French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline & French Laboratories Ltd filed Critical Smith Kline & French Laboratories Ltd
Publication of JPS57206683A publication Critical patent/JPS57206683A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Air-Conditioning For Vehicles (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP57089611A 1981-05-30 1982-05-25 Pyrimidone salt, manufacture and medicinal composition containing same Pending JPS57206683A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8116615 1981-05-30

Publications (1)

Publication Number Publication Date
JPS57206683A true JPS57206683A (en) 1982-12-18

Family

ID=10522169

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57089611A Pending JPS57206683A (en) 1981-05-30 1982-05-25 Pyrimidone salt, manufacture and medicinal composition containing same

Country Status (12)

Country Link
US (1) US4450161A (enExample)
EP (1) EP0067579B1 (enExample)
JP (1) JPS57206683A (enExample)
AT (1) ATE9345T1 (enExample)
AU (1) AU8431082A (enExample)
DE (1) DE3260719D1 (enExample)
DK (1) DK230482A (enExample)
ES (1) ES512629A0 (enExample)
GB (1) GB2112380A (enExample)
GR (1) GR76450B (enExample)
PT (1) PT74958B (enExample)
ZA (1) ZA823766B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
PH16240A (en) * 1978-04-11 1983-08-11 Smith Kline French Lab Process for making histamine antagonist
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones

Also Published As

Publication number Publication date
ZA823766B (en) 1983-04-27
ATE9345T1 (de) 1984-09-15
PT74958B (en) 1983-12-23
DK230482A (da) 1982-12-01
AU8431082A (en) 1982-12-09
GR76450B (enExample) 1984-08-10
US4450161A (en) 1984-05-22
PT74958A (en) 1982-06-01
ES8304094A1 (es) 1983-02-16
GB2112380A (en) 1983-07-20
ES512629A0 (es) 1983-02-16
EP0067579B1 (en) 1984-09-12
DE3260719D1 (en) 1984-10-18
EP0067579A1 (en) 1982-12-22

Similar Documents

Publication Publication Date Title
NZ237565A (en) Substituted thiazolidinones, oxazolidinones or imidazolidinones and antiinflammatory pharmaceutical compositions thereof
US4476308B1 (enExample)
DE3587164D1 (de) Antidiabetikaverbindungen.
IE790364L (en) 2-nitro aminopyrimidone derivatives
GR81397B (enExample)
IT1206130B (it) Composti per abbassare i livelli dei lipidi.
DE3260719D1 (en) A pyrimidone salt and its preparation
SE8201019L (sv) Amino-2,1,3-bensotiadiazol- och -bensooxadiazolderivat, deras framstellningoch lekemedel innehallande desamma
AU545216B2 (en) 2-(4-benzylpiperidino)-1-(4 halo-phenyl)piopan-1-ol
DK91282A (da) 7alfa-alkoxycarbonyl-15beta,16beta-methylen-4-androstener,fremgangsmaade til deres fremstilling og anvendelse som laegemiddel
NO942668L (no) Alkylderivater av trazodon med CNS-aktivitet
ATE23715T1 (de) Neue 1-acetonyl-2-(phenylimino)-imidazolidine, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung.
IT1151802B (it) Immidazolil-propionitrili,procedimento per la preparazione di queste composti nonche' mezzi biocidi che li contengono
PT86610A (pt) Process for the preparation of a fungicidal compound containing 1-aminoethyl-3-aryl-4-cyano-pyrroles
DE3161462D1 (en) Cephalosporins, processes for their preparation and pharmaceutical compositions containing these compounds
ES8706127A1 (es) Procedimiento para preparar derivados de imidazol con acti- vidad antitrombotica
DE3271755D1 (en) 5-aminomethyl-2,3-dihydro-2-oxo-1h-imidazole-4-carboxylic acid derivatives
JPS5677276A (en) Guanidine compound* its manufacture and composition containing it
GR79114B (enExample)
ATE36536T1 (de) Phosphoroimidate.
DK424189D0 (da) Hemiphosphat-hemihydrat af 2-(1-pentyl-3-guanidino-4-imidazolyl)thiazol
IT8024108A0 (it) Derivati del2-solfinil-5-solfonil-1,3,4-tiadiazolo, procedimento per la fabbricazione di questi composti nonche' mezzi fungicidi che licontengono.
IT1140281B (it) Procedimento per la preparazione di 4-idrossi-2-metil-n-(2-piridil)-2h-1,2-benzotiazin-3-carbossamide 1,1-diossido